US2022054710A1PendingUtilityA1
Decellularization of Plant Cell Culture Materials for Tissue Engineering and Drug Delivery
Est. expiryAug 22, 2038(~12.1 yrs left)· nominal 20-yr term from priority
A61L 27/3637A61L 27/3687A61L 27/54C12Y 304/24027C12Y 304/24007C12N 2533/54C12N 2509/00C12Y 301/01C12Y 304/21004A61L 27/3695C12N 5/0025A61L 2300/254C12Y 302/01022A61L 2300/414
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are enzymatically decellularized cells, and methods of producing said cells, that can be used in a scaffold. The scaffolds featured herein are biocompatible and can comprise decellularized cells that have been modified to express a bioactive agent or molecule.
Claims
exact text as granted — not AI-modified1 . A method for decellularizing cells, the method comprising:
contacting a plurality of cells with a composition comprising a nuclease, thereby decellularizing the plurality of cells, wherein the plurality of cells are cellulose producing cells.
2 . The method of claim 1 , wherein the nuclease is DNasel.
3 . The method of claim 1 , wherein the plurality of cells are plant cells.
4 . The method of claim 1 further comprising culturing the plurality of cells prior to contacting the cells with the nuclease.
5 . The method of claim 1 , further comprising isolating cellular material from the cultured plurality of cells.
6 . A scaffold comprising decellularized cells derived from a cellulose producing organism and a bioactive molecule.
7 . The scaffold of claim 6 , wherein the bioactive molecule is attached to the decellularized cells.
8 . The scaffold of claim 6 , wherein the decellularized cells are enzymatically decellularized plant-derived cells.
9 . The scaffold of claim 6 , wherein the bioactive molecule is VEGF, bFGF, IL-2, or a molecule that directs mammalian cell expansion, differentiation, or a cellular response.
10 . The scaffold of claim 6 , wherein the decellularized cells are cultured cells.
11 .- 13 . (canceled)
14 . A method of producing a biocompatible scaffold, the method comprising:
contacting the cellulose producing cells with a composition comprising a nuclease, thereby producing decellularized cells; and creating a scaffold from the decellularized modified cells.
15 . The method of claim 14 further comprising modifying the cellulose producing cells to express a bioactive agent.
16 . The method of claim 14 , wherein the bioactive agent is a molecule that directs mammalian cell expansion, differentiation, or a cellular response.
17 . The method of claim 14 , wherein the bioactive agent is imbedded, attached, or associated with the cell walls of the cellulose producing cells.
18 . The method of claim 14 , wherein the plurality of cellulose producing cells are cultured cells.
19 . The method of claim 14 , wherein the nuclease is DNasel.
20 . The method of claim 14 , wherein the composition further comprises trypsin, collagenase, lipase, dispase, thermolysin, and α-galactosidase.Join the waitlist — get patent alerts
Track US2022054710A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.